|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Lucira Health, Inc. (LHDX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
38,310,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lucira Health is a medical technology company focused on the development and commercialization of infectious disease test kits. Co. has developed a testing platform that produces molecular testing in a single-use test kit that is powered by two AA batteries and fits in the palm of a hand. Co.'s primary commercially available polymerase chain reaction-quality diagnostic test is the LUCIRA COVID-19 All-In-One Test Kit.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
30,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$51,300 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
974,177 |
| Total Sell Value |
$0 |
$0 |
$0 |
$985,816 |
| Total People Sold |
0 |
0 |
0 |
8 |
| Total Sell Transactions |
0 |
0 |
0 |
27 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lamond David |
Director |
– • – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
146,385 |
146,385 |
|
- |
|
| Yen Tuff |
Director |
– • – |
2021-02-09 |
4 |
A |
$0.00 |
$1,852,660 |
I/I |
2,241,668 |
1,013,473 |
|
- |
|
| Boeding Chad |
CEO of 10% Owner |
– – – |
2021-02-05 |
4 |
B |
$17.00 |
$58,849,988 |
D/D |
3,461,764 |
3,461,764 |
2.44 |
- |
|
| Boeding Chad |
CEO of 10% Owner |
– – – |
2021-02-05 |
4 |
A |
$0.00 |
$12,503,075 |
D/D |
9,694,761 |
735,475 |
|
- |
|
| Engelson Erik T. |
President and Chief ExecutiveO |
• • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
238,105 |
|
- |
|
| George Dan |
CFO and TreasurerOfficer |
• – – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,640 |
|
- |
|
| Mitra Debkishore |
Chief Technology OfficerOffice |
• • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
371,203 |
|
- |
|
| Lamond David |
Director |
– • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,281 |
|
- |
|
58 Records found
|
|
Page 3 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
